STI Prevention in the Era of Biomedical HIV Intervention Part I Incident chlamydia, gonorrhea, and syphilis have risen sharply among men in the United States and other industrialized countries, with syphilis disproportionately high among MSM. 1 This study investigates the relationship between biomedical HIV interventions and recent increases in STI incidence in AIDS-affected communities across the U.S. As Truvada (and now, Descovy) and concepts like U=U (undetectable equals untrasmittable) move across continents and into local formularies, traditional methods of HIV prevention are being destabilized. For the past 40 years, under the guidance of CDC and WHO, public health departments have focused primarily on preventing HIV by promoting abstinence, behavior change, and condoms (ABCs). However, the biomedical paradigm is shifting global strategies to address this disease. Anti-retroviral drugs can reduce the infectiousness of people living with HIV by about 96%--treatment a
Writings in Anthropology & Public Health